Sort
15,842 grants matching “pancreatic cancer”
TARGETING HEPATOCYTE-DERIVED FACTORS TO IMPROVE THE EFFICACY OF IMMUNOTHERAPY IN PANCREATIC CANCER
$495,379Trustees Of The University Of Pennsylvania, The · · FY2021 · Department of the Army
Machine learning accelerated on-line adaptive replanning
$495,299X. Allen Li · Medical College Of Wisconsin · R01 · FY2021 · CA
UCLA Multifunctional Mesoporous Silica Nanoparticle Platform for Treatment of Pancreas Cancer
$495,258Andre Elias Nel · University Of California Los Angeles · U01 · FY2016 · CA
Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment
$495,129Dai Fukumura · Massachusetts General Hospital · R01 · FY2017 · CA
Administrative Core
$495,090Haifa Shen · Methodist Hospital Research Institute · U54 · FY2018 · CA
Leveraging cross-cancer shared heritability to better understand the genetic architecture of cancer
$494,993Sara Lindstroem · University Of Washington · U01 · FY2023 · CA
Transcriptomic origins of cancer
$494,875Sridhar Hannenhalli · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Combined radiation acoustics and ultrasound imaging for real-time guidance in radiotherapy
$494,767Issam M. El Naqa · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2020 · CA
A pooling project on alcohol use and risk of cancers with inconsistent prior evidence, with an emphasis in non-smokers.
$494,761Pietro Ferrari · International Agency For Res On Cancer · R01 · FY2017 · AA
Project 2: Cell Migration in Mechanically Complex Microenvironments
$494,729Paolo Provenzano · University Of Minnesota · U54 · FY2020 · CA
Controllable In Vivo Genome Editing for Immune-Checkpoint Blockade in Solid Tumors
$494,605Sheng Tong · University Of Kentucky · R01 · FY2022 · EB
NGF recruits nerve fibers to reprogram an immunosuppressive microenvironment in melanoma
$494,541Xiao-Fan Wang · Duke University · R01 · FY2023 · CA
Targeting the Unfolded Protein Response in PanNETs
$494,442Scott A Oakes · University Of Chicago · R01 · FY2021 · CA
Targeting the Unfolded Protein Response in PanNETs
$494,442Scott A Oakes · University Of Chicago · R01 · FY2020 · CA
Controllable In Vivo Genome Editing for Immune-Checkpoint Blockade in Solid Tumors
$494,410Sheng Tong · University Of Kentucky · R01 · FY2021 · EB
NGF recruits nerve fibers to reprogram an immunosuppressive microenvironment in melanoma
$494,201Xiao-Fan Wang · Duke University · R01 · FY2022 · CA
Alpha particles combined with ATR inhibition to activate the immune system: mechanisms and pre-clinical translation
$494,190Gabriel Oliveira Sawakuchi · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Overcoming stromal barriers to therapeutics in pancreas cancer
$494,110Sunil R Hingorani · Fred Hutchinson Cancer Research Center · R01 · FY2014 · CA
The Ohio State University Pancreatic Disorders Network (OSU-PDN)
$494,029Darwin Lewis Conwell · Ohio State University · U01 · FY2015 · DK
Novel Role of Ref-1 in Pancreatic Cancer Etiology and Progression
$493,963Mark R. Kelley · Indiana University Indianapolis · R01 · FY2017 · CA
Novel Role of Ref-1 in Pancreatic Cancer Etiology and Progression
$493,963Mark R. Kelley · Indiana University Indianapolis · R01 · FY2013 · CA
Novel Role of Ref-1 in Pancreatic Cancer Etiology and Progression
$493,963Mark R. Kelley · Indiana University Indianapolis · R01 · FY2015 · CA
Novel Role of Ref-1 in Pancreatic Cancer Etiology and Progression
$493,963Mark R. Kelley · Indiana University Indianapolis · R01 · FY2016 · CA
Project 1: Inhibition of Metastasis Utilizing Pharmacological Ascorbate in Pancreas Cancer
$493,783Joseph J Cullen · University Of Iowa · P01 · FY2019 · CA
Mechanisms of Venous Thromboembolism in Cancer
$493,735Nigel Mackman · Univ Of North Carolina Chapel Hill · R01 · FY2010 · HL